• Profile
Close

Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma. A multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma

Journal of the European Academy of Dermatology and Venereology Oct 14, 2019

Fernández-de-Misa R, Hernández-Machín B, Combalía A, et al. - Among 108 patients (median age at diagnosis was 58 years) with primary cutaneous anaplastic large cell lymphoma (PCALCL), researchers identified prognostic factors for specific survival. They retrospectively reviewed patients with PCALC diagnosed from May 1986 to August 2017 in 16 University Departments using the convenience sampling method. All of the study participants showed T1-3N0M0 stages. Data reported that 70% of the cases presented with a solitary lesion, mostly at the limbs. After first-line treatment, complete response rate was 87% and no advantage was found for any of them (surgery, radiotherapy, chemotherapy or other approaches). It was noted that 11% and 2%, respectively, were nodal and visceral progression rate. An independent predictive parameter for shorter survival was nodal progression. In patients with PCALCL, multiple cutaneous lesions at presentation, early skin relapse and nodal progression show worse prognosis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay